BioXcel Therapeutics, Inc. (BTAI) — Dilution Risk Analysis
Current Snapshot
BioXcel Therapeutics, Inc. (BTAI) has a DilutionWatch score of 65/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 65/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 1, 4 7, 424B5 1, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-6215-xbrl_warrant |
| 4 | 2026-03-16 | 0001104659-26-028718 |
| 4 | 2026-03-16 | 0001104659-26-028720 |
| 4 | 2026-03-16 | 0001104659-26-028721 |
| 4 | 2026-03-16 | 0001104659-26-028722 |
| 424B5 | 2026-03-11 | 0001104659-26-026158 |
| 8-K | 2026-03-11 | 0001104659-26-026409 |
| 4 | 2026-01-12 | 0001104659-26-002973 |
| 4 | 2026-01-12 | 0001104659-26-002975 |
| 4 | 2026-01-12 | 0001104659-26-002976 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $62,500,000 | Source |
| Cash runway | 1 months | Source |
| Three-year share count growth | 755.56% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 65/10) Source
- Cash Runway
- 1 months Source
- ATM Offering Capacity Remaining
- $62,500,000 Source
- Share Count Growth (3-Year)
- 755.56% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.